CustoMed News
1 article
growth-positive
/PRNewswire/ -- CustoMED, a pioneer in AI-driven, surgeon-first platforms for patient-specific orthopedic solutions, today announced the successful completion...
CustoMED, a leader in AI-driven, patient-specific orthopedic solutions, has successfully completed a seed funding round, raising a total of $6 million. The investment comes from Longevity Venture Partners, Varana Capital, Flag Capital, the Israel Innovation Authority, and Avishai Abrahami. CustoMEDs platform uses AI and 3D printing to create patient-specific surgical tools and implants, enhancing the precision and speed of orthopedic surgeries. The company plans to use the funds to expand its automated orthopedic solutions and achieve regulatory milestones in the U.S. and EU by 2026. CustoMED is part of Sheba Medical Centers ARC Innovation ecosystem, which supports the development of new medical technologies.
InvestmentProduct Stage